CA2387146A1 - Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy - Google Patents

Info

Publication number

CA2387146A1

CA2387146A1 CA002387146A CA2387146A CA2387146A1 CA 2387146 A1 CA2387146 A1 CA 2387146A1 CA 002387146 A CA002387146 A CA 002387146A CA 2387146 A CA2387146 A CA 2387146A CA 2387146 A1 CA2387146 A1 CA 2387146A1

Authority

CA

Canada

Prior art keywords

cells

nucleic acid

vectors

apoptosis

gene transfer

Prior art date

1999-10-12

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 239000013598 vector Substances 0.000 title claims abstract description 262
• 108090000623 proteins and genes Proteins 0.000 title claims abstract description 198
• 238000012546 transfer Methods 0.000 title claims abstract description 70
• 208000023275 Autoimmune disease Diseases 0.000 title claims description 36
• 201000010099 disease Diseases 0.000 title description 28
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 28
• 238000002560 therapeutic procedure Methods 0.000 title description 11
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 150
• 230000006907 apoptotic process Effects 0.000 claims abstract description 111
• 108091007433 antigens Proteins 0.000 claims abstract description 62
• 102000036639 antigens Human genes 0.000 claims abstract description 62
• 239000000427 antigen Substances 0.000 claims abstract description 61
• 239000003446 ligand Substances 0.000 claims abstract description 55
• 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 47
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 43
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 43
• 102000004190 Enzymes Human genes 0.000 claims abstract description 26
• 108090000790 Enzymes Proteins 0.000 claims abstract description 26
• 206010010144 Completed suicide Diseases 0.000 claims abstract description 21
• 230000006909 anti-apoptosis Effects 0.000 claims abstract description 21
• 102000004169 proteins and genes Human genes 0.000 claims description 92
• 230000014509 gene expression Effects 0.000 claims description 83
• 241000700605 Viruses Species 0.000 claims description 45
• 230000001939 inductive effect Effects 0.000 claims description 43
• 102000011727 Caspases Human genes 0.000 claims description 38
• 108010076667 Caspases Proteins 0.000 claims description 38
• 241000701161 unidentified adenovirus Species 0.000 claims description 28
• 208000015181 infectious disease Diseases 0.000 claims description 24
• 230000004054 inflammatory process Effects 0.000 claims description 24
• 108020005544 Antisense RNA Proteins 0.000 claims description 23
• 230000003612 virological effect Effects 0.000 claims description 22
• 108020004440 Thymidine kinase Proteins 0.000 claims description 20
• 102000006601 Thymidine Kinase Human genes 0.000 claims description 19
• 102000006386 Myelin Proteins Human genes 0.000 claims description 18
• 108010083674 Myelin Proteins Proteins 0.000 claims description 18
• 210000005012 myelin Anatomy 0.000 claims description 18
• 239000013612 plasmid Substances 0.000 claims description 18
• 102000015212 Fas Ligand Protein Human genes 0.000 claims description 17
• 108010039471 Fas Ligand Protein Proteins 0.000 claims description 17
• 210000004962 mammalian cell Anatomy 0.000 claims description 17
• 201000006417 multiple sclerosis Diseases 0.000 claims description 16
• 241001430294 unidentified retrovirus Species 0.000 claims description 15
• 230000001419 dependent effect Effects 0.000 claims description 14
• 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims description 12
• 241000894006 Bacteria Species 0.000 claims description 11
• 102000003886 Glycoproteins Human genes 0.000 claims description 10
• 108090000288 Glycoproteins Proteins 0.000 claims description 10
• 230000001580 bacterial effect Effects 0.000 claims description 10
• 210000005260 human cell Anatomy 0.000 claims description 8
• 206010039073 rheumatoid arthritis Diseases 0.000 claims description 8
• 102100028682 Claudin-11 Human genes 0.000 claims description 7
• 108050007280 Claudin-11 Proteins 0.000 claims description 7
• 241001465754 Metazoa Species 0.000 claims description 7
• 239000003112 inhibitor Substances 0.000 claims description 7
• 108010009685 Cholinergic Receptors Proteins 0.000 claims description 6
• 241000702421 Dependoparvovirus Species 0.000 claims description 6
• 108010013731 Myelin-Associated Glycoprotein Proteins 0.000 claims description 6
• 108010076181 Proinsulin Proteins 0.000 claims description 6
• 102000034337 acetylcholine receptors Human genes 0.000 claims description 6
• 230000009885 systemic effect Effects 0.000 claims description 6
• 241000710929 Alphavirus Species 0.000 claims description 5
• 108010080611 Cytosine Deaminase Proteins 0.000 claims description 5
• 102000000311 Cytosine Deaminase Human genes 0.000 claims description 5
• 101710199257 Peripheral myelin protein 22 Proteins 0.000 claims description 5
• 102100035917 Peripheral myelin protein 22 Human genes 0.000 claims description 5
• 208000036142 Viral infection Diseases 0.000 claims description 5
• 208000037976 chronic inflammation Diseases 0.000 claims description 5
• 230000006020 chronic inflammation Effects 0.000 claims description 5
• 108010041801 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Proteins 0.000 claims description 4
• 201000004384 Alopecia Diseases 0.000 claims description 4
• 101001000628 Rattus norvegicus Peripheral myelin protein 22 Proteins 0.000 claims description 4
• 206010052779 Transplant rejections Diseases 0.000 claims description 4
• 208000006454 hepatitis Diseases 0.000 claims description 4
• 239000002502 liposome Substances 0.000 claims description 4
• 210000004248 oligodendroglia Anatomy 0.000 claims description 4
• 241001529453 unidentified herpesvirus Species 0.000 claims description 4
• 102100040458 2',3'-cyclic-nucleotide 3'-phosphodiesterase Human genes 0.000 claims description 3
• KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-amino-2-[(2,5-diamino-5-oxopentanoyl)amino]hexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-(diaminomethylideneamino)p Chemical compound C1CCN(C(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC(=O)C(N)CCC(N)=O)C1C(=O)NC(CO)C(=O)NC(CCC(N)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=C(O)C=C1 KISWVXRQTGLFGD-UHFFFAOYSA-N 0.000 claims description 3
• 206010001367 Adrenal insufficiency Diseases 0.000 claims description 3
• 206010002556 Ankylosing Spondylitis Diseases 0.000 claims description 3
• 206010003827 Autoimmune hepatitis Diseases 0.000 claims description 3
• 208000035143 Bacterial infection Diseases 0.000 claims description 3
• 108010051152 Carboxylesterase Proteins 0.000 claims description 3
• 102000013392 Carboxylesterase Human genes 0.000 claims description 3
• 206010008909 Chronic Hepatitis Diseases 0.000 claims description 3
• 208000015943 Coeliac disease Diseases 0.000 claims description 3
• 206010009900 Colitis ulcerative Diseases 0.000 claims description 3
• 208000011231 Crohn disease Diseases 0.000 claims description 3
• 108010033174 Deoxycytidine kinase Proteins 0.000 claims description 3
• 102100029588 Deoxycytidine kinase Human genes 0.000 claims description 3
• 101710175001 E1B protein, small T-antigen Proteins 0.000 claims description 3
• 241000700721 Hepatitis B virus Species 0.000 claims description 3
• 101000850887 Human herpesvirus 8 type P (isolate GK18) Viral FLICE protein Proteins 0.000 claims description 3
• 101710192602 Latent membrane protein 1 Proteins 0.000 claims description 3
• 241000186781 Listeria Species 0.000 claims description 3
• 241000712079 Measles morbillivirus Species 0.000 claims description 3
• 102000004459 Nitroreductase Human genes 0.000 claims description 3
• 201000011152 Pemphigus Diseases 0.000 claims description 3
• 208000007048 Polymyalgia Rheumatica Diseases 0.000 claims description 3
• 101710101148 Probable 6-oxopurine nucleoside phosphorylase Proteins 0.000 claims description 3
• 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 3
• 201000004681 Psoriasis Diseases 0.000 claims description 3
• 102000030764 Purine-nucleoside phosphorylase Human genes 0.000 claims description 3
• 101710132082 Pyrimidine/purine nucleoside phosphorylase Proteins 0.000 claims description 3
• 101710160580 Schwann cell myelin protein Proteins 0.000 claims description 3
• 208000021386 Sjogren Syndrome Diseases 0.000 claims description 3
• 208000006045 Spondylarthropathies Diseases 0.000 claims description 3
• 201000006704 Ulcerative Colitis Diseases 0.000 claims description 3
• 208000017515 adrenocortical insufficiency Diseases 0.000 claims description 3
• 231100000360 alopecia Toxicity 0.000 claims description 3
• 210000004102 animal cell Anatomy 0.000 claims description 3
• 208000022362 bacterial infectious disease Diseases 0.000 claims description 3
• 201000001981 dermatomyositis Diseases 0.000 claims description 3
• 239000003814 drug Substances 0.000 claims description 3
• 206010014599 encephalitis Diseases 0.000 claims description 3
• 108020001507 fusion proteins Proteins 0.000 claims description 3
• 102000037865 fusion proteins Human genes 0.000 claims description 3
• 108010062699 gamma-Glutamyl Hydrolase Proteins 0.000 claims description 3
• 208000002672 hepatitis B Diseases 0.000 claims description 3
• 208000010710 hepatitis C virus infection Diseases 0.000 claims description 3
• 206010025135 lupus erythematosus Diseases 0.000 claims description 3
• 108020001162 nitroreductase Proteins 0.000 claims description 3
• 201000001976 pemphigus vulgaris Diseases 0.000 claims description 3
• 208000005987 polymyositis Diseases 0.000 claims description 3
• 229940124597 therapeutic agent Drugs 0.000 claims description 3
• 206010043778 thyroiditis Diseases 0.000 claims description 3
• 102000000503 Collagen Type II Human genes 0.000 claims description 2
• 108010041390 Collagen Type II Proteins 0.000 claims description 2
• 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 claims description 2
• 102000003849 Cytochrome P450 Human genes 0.000 claims description 2
• 206010012468 Dermatitis herpetiformis Diseases 0.000 claims description 2
• 241000725578 Equid gammaherpesvirus 2 Species 0.000 claims description 2
• 241000230501 Equine herpesvirus sp. Species 0.000 claims description 2
• 102100039289 Glial fibrillary acidic protein Human genes 0.000 claims description 2
• 101710193519 Glial fibrillary acidic protein Proteins 0.000 claims description 2
• 241001502974 Human gammaherpesvirus 8 Species 0.000 claims description 2
• 108050004848 Islet cell autoantigen 1 Proteins 0.000 claims description 2
• 102100027640 Islet cell autoantigen 1 Human genes 0.000 claims description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
• 102000047918 Myelin Basic Human genes 0.000 claims description 2
• 101710107068 Myelin basic protein Proteins 0.000 claims description 2
• 101150092861 ORF71 gene Proteins 0.000 claims description 2
• 101900031254 Saccharomyces cerevisiae Uracil phosphoribosyltransferase Proteins 0.000 claims description 2
• 241000701062 Saimiriine gammaherpesvirus 2 Species 0.000 claims description 2
• 241000607142 Salmonella Species 0.000 claims description 2
• 241000607768 Shigella Species 0.000 claims description 2
• 206010040550 Shigella infections Diseases 0.000 claims description 2
• 102100028601 Transaldolase Human genes 0.000 claims description 2
• 108020004530 Transaldolase Proteins 0.000 claims description 2
• 108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 claims description 2
• 210000004507 artificial chromosome Anatomy 0.000 claims description 2
• 210000005046 glial fibrillary acidic protein Anatomy 0.000 claims description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
• 241001515965 unidentified phage Species 0.000 claims description 2
• 108091000036 uracil phosphoribosyltransferase Proteins 0.000 claims description 2
• 102000000563 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Human genes 0.000 claims 1
• 101710154868 60 kDa heat shock protein, mitochondrial Proteins 0.000 claims 1
• 102100038222 60 kDa heat shock protein, mitochondrial Human genes 0.000 claims 1
• 102100035857 Glutamate decarboxylase 2 Human genes 0.000 claims 1
• 101000844721 Homo sapiens Deleted in malignant brain tumors 1 protein Proteins 0.000 claims 1
• 101000873786 Homo sapiens Glutamate decarboxylase 2 Proteins 0.000 claims 1
• 101001111714 Homo sapiens RING-box protein 2 Proteins 0.000 claims 1
• 101000901226 Homo sapiens S-arrestin Proteins 0.000 claims 1
• 102000055324 Myelin Proteolipid Human genes 0.000 claims 1
• 101710094913 Myelin proteolipid protein Proteins 0.000 claims 1
• 102000017099 Myelin-Associated Glycoprotein Human genes 0.000 claims 1
• 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims 1
• 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims 1
• 102000013537 Thymidine Phosphorylase Human genes 0.000 claims 1
• 206010003246 arthritis Diseases 0.000 claims 1
• 230000002123 temporal effect Effects 0.000 claims 1
• 210000004027 cell Anatomy 0.000 description 216
• 210000001744 T-lymphocyte Anatomy 0.000 description 130
• 210000000612 antigen-presenting cell Anatomy 0.000 description 91
• 235000018102 proteins Nutrition 0.000 description 90
• 241000699670 Mus sp. Species 0.000 description 56
• 102000005962 receptors Human genes 0.000 description 39
• 108020003175 receptors Proteins 0.000 description 39
• 210000002540 macrophage Anatomy 0.000 description 36
• 101150064015 FAS gene Proteins 0.000 description 32
• 210000004443 dendritic cell Anatomy 0.000 description 32
• 108090000765 processed proteins & peptides Proteins 0.000 description 32
• 230000001177 retroviral effect Effects 0.000 description 32
• 210000002865 immune cell Anatomy 0.000 description 31
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 28
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 28
• 102100040247 Tumor necrosis factor Human genes 0.000 description 28
• 238000004806 packaging method and process Methods 0.000 description 28
• 210000000056 organ Anatomy 0.000 description 27
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 27
• 241000699666 Mus <mouse, genus> Species 0.000 description 26
• 238000000034 method Methods 0.000 description 26
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 24
• 102000004196 processed proteins & peptides Human genes 0.000 description 24
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 23
• 230000001404 mediated effect Effects 0.000 description 20
• 108020004414 DNA Proteins 0.000 description 19
• 206010061218 Inflammation Diseases 0.000 description 19
• 229920001184 polypeptide Polymers 0.000 description 19
• 102100026693 FAS-associated death domain protein Human genes 0.000 description 18
• 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 description 18
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 18
• 230000027455 binding Effects 0.000 description 18
• 230000001413 cellular effect Effects 0.000 description 18
• 230000001105 regulatory effect Effects 0.000 description 18
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 18
• 241000701022 Cytomegalovirus Species 0.000 description 17
• 102000004091 Caspase-8 Human genes 0.000 description 16
• 108090000538 Caspase-8 Proteins 0.000 description 16
• 241000701029 Murid betaherpesvirus 1 Species 0.000 description 16
• 206010012601 diabetes mellitus Diseases 0.000 description 15
• 230000000638 stimulation Effects 0.000 description 15
• 210000001519 tissue Anatomy 0.000 description 15
• 210000003719 b-lymphocyte Anatomy 0.000 description 14
• 238000006243 chemical reaction Methods 0.000 description 14
• 238000002474 experimental method Methods 0.000 description 14
• 239000012634 fragment Substances 0.000 description 14
• 230000003993 interaction Effects 0.000 description 14
• 210000003734 kidney Anatomy 0.000 description 14
• 210000004698 lymphocyte Anatomy 0.000 description 14
• 239000002773 nucleotide Substances 0.000 description 14
• 125000003729 nucleotide group Chemical group 0.000 description 14
• 102100025752 CASP8 and FADD-like apoptosis regulator Human genes 0.000 description 13
• 230000004913 activation Effects 0.000 description 13
• 230000002950 deficient Effects 0.000 description 13
• 230000006870 function Effects 0.000 description 13
• 210000002443 helper t lymphocyte Anatomy 0.000 description 13
• 230000006882 induction of apoptosis Effects 0.000 description 13
• 210000004185 liver Anatomy 0.000 description 13
• 238000007799 mixed lymphocyte reaction assay Methods 0.000 description 13
• 210000001616 monocyte Anatomy 0.000 description 13
• 101710100501 CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 12
• 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 12
• 230000006378 damage Effects 0.000 description 12
• 230000000694 effects Effects 0.000 description 12
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 11
• 210000003169 central nervous system Anatomy 0.000 description 11
• 238000003776 cleavage reaction Methods 0.000 description 11
• 239000003184 complementary RNA Substances 0.000 description 11
• 238000001415 gene therapy Methods 0.000 description 11
• 210000000987 immune system Anatomy 0.000 description 11
• 239000002245 particle Substances 0.000 description 11
• 230000007017 scission Effects 0.000 description 11
• 239000000126 substance Substances 0.000 description 11
• 102000004127 Cytokines Human genes 0.000 description 10
• 108090000695 Cytokines Proteins 0.000 description 10
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 10
• 108700012411 TNFSF10 Proteins 0.000 description 10
• 108020004566 Transfer RNA Proteins 0.000 description 10
• 230000000890 antigenic effect Effects 0.000 description 10
• 230000003305 autocrine Effects 0.000 description 10
• 238000011161 development Methods 0.000 description 10
• 239000003102 growth factor Substances 0.000 description 10
• 108020004999 messenger RNA Proteins 0.000 description 10
• 239000002243 precursor Substances 0.000 description 10
• 230000006820 DNA synthesis Effects 0.000 description 9
• 102000035181 adaptor proteins Human genes 0.000 description 9
• 108091005764 adaptor proteins Proteins 0.000 description 9
• 239000000470 constituent Substances 0.000 description 9
• -1 dFasL Species 0.000 description 9
• 210000003527 eukaryotic cell Anatomy 0.000 description 9
• 230000002401 inhibitory effect Effects 0.000 description 9
• 210000004072 lung Anatomy 0.000 description 9
• 230000037361 pathway Effects 0.000 description 9
• 230000010076 replication Effects 0.000 description 9
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 8
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 8
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 8
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 8
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 8
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 8
• 101000850748 Homo sapiens Tumor necrosis factor receptor type 1-associated DEATH domain protein Proteins 0.000 description 8
• 102000003814 Interleukin-10 Human genes 0.000 description 8
• 108090000174 Interleukin-10 Proteins 0.000 description 8
• 108090000978 Interleukin-4 Proteins 0.000 description 8
• 102000004388 Interleukin-4 Human genes 0.000 description 8
• 102100033081 Tumor necrosis factor receptor type 1-associated DEATH domain protein Human genes 0.000 description 8
• 230000001363 autoimmune Effects 0.000 description 8
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 8
• 230000006698 induction Effects 0.000 description 8
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
• 229940076144 interleukin-10 Drugs 0.000 description 8
• 108700004029 pol Genes Proteins 0.000 description 8
• 229940002612 prodrug Drugs 0.000 description 8
• 239000000651 prodrug Substances 0.000 description 8
• 238000001890 transfection Methods 0.000 description 8
• 241000271566 Aves Species 0.000 description 7
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 7
• 101000679903 Homo sapiens Tumor necrosis factor receptor superfamily member 25 Proteins 0.000 description 7
• 241000725303 Human immunodeficiency virus Species 0.000 description 7
• 108091054438 MHC class II family Proteins 0.000 description 7
• 241000714474 Rous sarcoma virus Species 0.000 description 7
• 241000700584 Simplexvirus Species 0.000 description 7
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 7
• 230000003213 activating effect Effects 0.000 description 7
• 208000032839 leukemia Diseases 0.000 description 7
• 238000004519 manufacturing process Methods 0.000 description 7
• 238000010172 mouse model Methods 0.000 description 7
• 244000052769 pathogen Species 0.000 description 7
• 230000001717 pathogenic effect Effects 0.000 description 7
• 210000005259 peripheral blood Anatomy 0.000 description 7
• 239000011886 peripheral blood Substances 0.000 description 7
• 238000002360 preparation method Methods 0.000 description 7
• 230000035755 proliferation Effects 0.000 description 7
• 230000001629 suppression Effects 0.000 description 7
• 231100000331 toxic Toxicity 0.000 description 7
• 230000002588 toxic effect Effects 0.000 description 7
• 238000011144 upstream manufacturing Methods 0.000 description 7
• 108090000566 Caspase-9 Proteins 0.000 description 6
• 102000004039 Caspase-9 Human genes 0.000 description 6
• 102000036292 Death effector domains Human genes 0.000 description 6
• 108091010866 Death effector domains Proteins 0.000 description 6
• 241000282412 Homo Species 0.000 description 6
• 101000610605 Homo sapiens Tumor necrosis factor receptor superfamily member 10A Proteins 0.000 description 6
• 102100030698 Interleukin-12 subunit alpha Human genes 0.000 description 6
• 108091054437 MHC class I family Proteins 0.000 description 6
• 102000043131 MHC class II family Human genes 0.000 description 6
• IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 6
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 6
• 108010067390 Viral Proteins Proteins 0.000 description 6
• 230000000903 blocking effect Effects 0.000 description 6
• 239000012636 effector Substances 0.000 description 6
• 239000013604 expression vector Substances 0.000 description 6
• 230000028993 immune response Effects 0.000 description 6
• 238000000338 in vitro Methods 0.000 description 6
• 230000003834 intracellular effect Effects 0.000 description 6
• 239000003550 marker Substances 0.000 description 6
• 230000007246 mechanism Effects 0.000 description 6
• 239000012528 membrane Substances 0.000 description 6
• 210000003470 mitochondria Anatomy 0.000 description 6
• 206010028417 myasthenia gravis Diseases 0.000 description 6
• 230000008506 pathogenesis Effects 0.000 description 6
• 101150088264 pol gene Proteins 0.000 description 6
• 238000013519 translation Methods 0.000 description 6
• 238000002054 transplantation Methods 0.000 description 6
• 108090000394 Erythropoietin Proteins 0.000 description 5
• 108010002350 Interleukin-2 Proteins 0.000 description 5
• 102000000588 Interleukin-2 Human genes 0.000 description 5
• 108090001005 Interleukin-6 Proteins 0.000 description 5
• 102000043129 MHC class I family Human genes 0.000 description 5
• 241000124008 Mammalia Species 0.000 description 5
• 102100021831 Myelin-associated glycoprotein Human genes 0.000 description 5
• 108091008874 T cell receptors Proteins 0.000 description 5
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 5
• 241000700618 Vaccinia virus Species 0.000 description 5
• 229940024606 amino acid Drugs 0.000 description 5
• 235000001014 amino acid Nutrition 0.000 description 5
• 150000001413 amino acids Chemical group 0.000 description 5
• 239000011324 bead Substances 0.000 description 5
• 210000004369 blood Anatomy 0.000 description 5
• 239000008280 blood Substances 0.000 description 5
• 210000000170 cell membrane Anatomy 0.000 description 5
• 230000008878 coupling Effects 0.000 description 5
• 238000010168 coupling process Methods 0.000 description 5
• 238000005859 coupling reaction Methods 0.000 description 5
• 230000009089 cytolysis Effects 0.000 description 5
• 239000003623 enhancer Substances 0.000 description 5
• 108700004026 gag Genes Proteins 0.000 description 5
• 101150098622 gag gene Proteins 0.000 description 5
• 230000006872 improvement Effects 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 208000027866 inflammatory disease Diseases 0.000 description 5
• 238000011835 investigation Methods 0.000 description 5
• 210000000822 natural killer cell Anatomy 0.000 description 5
• 210000000496 pancreas Anatomy 0.000 description 5
• 210000001428 peripheral nervous system Anatomy 0.000 description 5
• 230000008569 process Effects 0.000 description 5
• 210000004116 schwann cell Anatomy 0.000 description 5
• 239000003440 toxic substance Substances 0.000 description 5
• 239000013607 AAV vector Substances 0.000 description 4
• 102100034524 Apoptotic protease-activating factor 1 Human genes 0.000 description 4
• 108090000397 Caspase 3 Proteins 0.000 description 4
• 102100029855 Caspase-3 Human genes 0.000 description 4
• 101710088341 Dermatopontin Proteins 0.000 description 4
• 102000003951 Erythropoietin Human genes 0.000 description 4
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 4
• 101000924629 Homo sapiens Apoptotic protease-activating factor 1 Proteins 0.000 description 4
• 101000591210 Homo sapiens Receptor-type tyrosine-protein phosphatase-like N Proteins 0.000 description 4
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 4
• 102000004877 Insulin Human genes 0.000 description 4
• 108090001061 Insulin Proteins 0.000 description 4
• 102000004889 Interleukin-6 Human genes 0.000 description 4
• 102000018697 Membrane Proteins Human genes 0.000 description 4
• 108010052285 Membrane Proteins Proteins 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 206010028980 Neoplasm Diseases 0.000 description 4
• 101100007739 Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) crmA gene Proteins 0.000 description 4
• 102100034091 Receptor-type tyrosine-protein phosphatase-like N Human genes 0.000 description 4
• 238000013459 approach Methods 0.000 description 4
• 239000011230 binding agent Substances 0.000 description 4
• 230000001684 chronic effect Effects 0.000 description 4
• 238000010276 construction Methods 0.000 description 4
• 230000000139 costimulatory effect Effects 0.000 description 4
• 210000000805 cytoplasm Anatomy 0.000 description 4
• 230000004069 differentiation Effects 0.000 description 4
• 229940105423 erythropoietin Drugs 0.000 description 4
• XRECTZIEBJDKEO-UHFFFAOYSA-N flucytosine Chemical compound NC1=NC(=O)NC=C1F XRECTZIEBJDKEO-UHFFFAOYSA-N 0.000 description 4
• 238000010348 incorporation Methods 0.000 description 4
• 230000005764 inhibitory process Effects 0.000 description 4
• 229940125396 insulin Drugs 0.000 description 4
• 210000005087 mononuclear cell Anatomy 0.000 description 4
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 4
• 231100000614 poison Toxicity 0.000 description 4
• 230000008488 polyadenylation Effects 0.000 description 4
• 238000003752 polymerase chain reaction Methods 0.000 description 4
• OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 4
• 230000006337 proteolytic cleavage Effects 0.000 description 4
• 210000003705 ribosome Anatomy 0.000 description 4
• 239000000758 substrate Substances 0.000 description 4
• 238000012360 testing method Methods 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• WYWHKKSPHMUBEB-UHFFFAOYSA-N tioguanine Chemical compound N1C(N)=NC(=S)C2=C1N=CN2 WYWHKKSPHMUBEB-UHFFFAOYSA-N 0.000 description 4
• 238000013518 transcription Methods 0.000 description 4
• 230000035897 transcription Effects 0.000 description 4
• 238000010361 transduction Methods 0.000 description 4
• 230000026683 transduction Effects 0.000 description 4
• 239000013603 viral vector Substances 0.000 description 4
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 3
• 101710132601 Capsid protein Proteins 0.000 description 3
• 108090000572 Caspase-10 Proteins 0.000 description 3
• 102000004068 Caspase-10 Human genes 0.000 description 3
• 241000255930 Chironomidae Species 0.000 description 3
• 101710094648 Coat protein Proteins 0.000 description 3
• 108020004705 Codon Proteins 0.000 description 3
• 102000053602 DNA Human genes 0.000 description 3
• 102000010170 Death domains Human genes 0.000 description 3
• 108050001718 Death domains Proteins 0.000 description 3
• 206010018429 Glucose tolerance impaired Diseases 0.000 description 3
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 3
• 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 3
• 101000610609 Homo sapiens Tumor necrosis factor receptor superfamily member 10D Proteins 0.000 description 3
• 108010002386 Interleukin-3 Proteins 0.000 description 3
• 102000000646 Interleukin-3 Human genes 0.000 description 3
• 108010002616 Interleukin-5 Proteins 0.000 description 3
• 108091092195 Intron Proteins 0.000 description 3
• 241000186779 Listeria monocytogenes Species 0.000 description 3
• 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102100028123 Macrophage colony-stimulating factor 1 Human genes 0.000 description 3
• 101710125418 Major capsid protein Proteins 0.000 description 3
• 108010060408 Member 25 Tumor Necrosis Factor Receptors Proteins 0.000 description 3
• 206010028372 Muscular weakness Diseases 0.000 description 3
• 108091061960 Naked DNA Proteins 0.000 description 3
• 101710141454 Nucleoprotein Proteins 0.000 description 3
• 108010047620 Phytohemagglutinins Proteins 0.000 description 3
• 101710083689 Probable capsid protein Proteins 0.000 description 3
• 108010007568 Protamines Proteins 0.000 description 3
• 102000007327 Protamines Human genes 0.000 description 3
• 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 3
• 206010039491 Sarcoma Diseases 0.000 description 3
• 241000607762 Shigella flexneri Species 0.000 description 3
• 108091081024 Start codon Proteins 0.000 description 3
• 230000024932 T cell mediated immunity Effects 0.000 description 3
• 230000005867 T cell response Effects 0.000 description 3
• 102100040110 Tumor necrosis factor receptor superfamily member 10D Human genes 0.000 description 3
• 229960004150 aciclovir Drugs 0.000 description 3
• MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 3
• 238000010171 animal model Methods 0.000 description 3
• 230000002238 attenuated effect Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 3
• 230000000295 complement effect Effects 0.000 description 3
• 239000002299 complementary DNA Substances 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 108700004025 env Genes Proteins 0.000 description 3
• 229960004413 flucytosine Drugs 0.000 description 3
• 230000037433 frameshift Effects 0.000 description 3
• 229940088597 hormone Drugs 0.000 description 3
• 239000005556 hormone Substances 0.000 description 3
• 230000001976 improved effect Effects 0.000 description 3
• 230000010354 integration Effects 0.000 description 3
• 108010027775 interleukin-1beta-converting enzyme inhibitor Proteins 0.000 description 3
• 210000001503 joint Anatomy 0.000 description 3
• 239000004816 latex Substances 0.000 description 3
• 229920000126 latex Polymers 0.000 description 3
• 238000012423 maintenance Methods 0.000 description 3
• 239000000203 mixture Substances 0.000 description 3
• 230000001885 phytohemagglutinin Effects 0.000 description 3
• 230000006659 positive regulation of apoptotic process Effects 0.000 description 3
• 230000000861 pro-apoptotic effect Effects 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 230000009467 reduction Effects 0.000 description 3
• 238000011160 research Methods 0.000 description 3
• 230000028327 secretion Effects 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 210000000952 spleen Anatomy 0.000 description 3
• 210000004989 spleen cell Anatomy 0.000 description 3
• 230000004083 survival effect Effects 0.000 description 3
• 230000008685 targeting Effects 0.000 description 3
• 210000001541 thymus gland Anatomy 0.000 description 3
• 210000004881 tumor cell Anatomy 0.000 description 3
• 244000052613 viral pathogen Species 0.000 description 3
• RJOXFJDOUQJOMQ-UHFFFAOYSA-N 6-sulfanylidene-3,7-dihydropurin-2-one Chemical compound S=C1NC(=O)NC2=C1NC=N2 RJOXFJDOUQJOMQ-UHFFFAOYSA-N 0.000 description 2
• 102100027211 Albumin Human genes 0.000 description 2
• 108010088751 Albumins Proteins 0.000 description 2
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
• 241000714230 Avian leukemia virus Species 0.000 description 2
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 2
• 108091007065 BIRCs Proteins 0.000 description 2
• DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 2
• 102000021350 Caspase recruitment domains Human genes 0.000 description 2
• 108091011189 Caspase recruitment domains Proteins 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 102000006303 Chaperonin 60 Human genes 0.000 description 2
• 108010058432 Chaperonin 60 Proteins 0.000 description 2
• 241000256135 Chironomus thummi Species 0.000 description 2
• 108700010070 Codon Usage Proteins 0.000 description 2
• 108010062580 Concanavalin A Proteins 0.000 description 2
• 108091035707 Consensus sequence Proteins 0.000 description 2
• 241000700626 Cowpox virus Species 0.000 description 2
• CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
• UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 2
• 102000018832 Cytochromes Human genes 0.000 description 2
• 108010052832 Cytochromes Proteins 0.000 description 2
• 230000004568 DNA-binding Effects 0.000 description 2
• 206010011968 Decreased immune responsiveness Diseases 0.000 description 2
• AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 2
• 108010062466 Enzyme Precursors Proteins 0.000 description 2
• 102000010911 Enzyme Precursors Human genes 0.000 description 2
• 241000206602 Eukaryota Species 0.000 description 2
• 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
• 208000007465 Giant cell arteritis Diseases 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 2
• WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 2
• 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
• 101001015220 Homo sapiens Myelin-associated oligodendrocyte basic protein Proteins 0.000 description 2
• 101000610602 Homo sapiens Tumor necrosis factor receptor superfamily member 10C Proteins 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 206010062016 Immunosuppression Diseases 0.000 description 2
• 102000014150 Interferons Human genes 0.000 description 2
• 108010050904 Interferons Proteins 0.000 description 2
• 108010065805 Interleukin-12 Proteins 0.000 description 2
• 102000013462 Interleukin-12 Human genes 0.000 description 2
• 108010002335 Interleukin-9 Proteins 0.000 description 2
• 102000000585 Interleukin-9 Human genes 0.000 description 2
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
• 108091026898 Leader sequence (mRNA) Proteins 0.000 description 2
• 241000713666 Lentivirus Species 0.000 description 2
• 102000008166 Member 25 Tumor Necrosis Factor Receptors Human genes 0.000 description 2
• 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
• 101100293261 Mus musculus Naa15 gene Proteins 0.000 description 2
• 102100032977 Myelin-associated oligodendrocyte basic protein Human genes 0.000 description 2
• 101150082943 NAT1 gene Proteins 0.000 description 2
• 108010005298 Oligodendrocyte-Myelin Glycoprotein Proteins 0.000 description 2
• 102100026746 Oligodendrocyte-myelin glycoprotein Human genes 0.000 description 2
• 108091034117 Oligonucleotide Proteins 0.000 description 2
• 206010033799 Paralysis Diseases 0.000 description 2
• 241000709664 Picornaviridae Species 0.000 description 2
• 108010039918 Polylysine Proteins 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 108010010974 Proteolipids Proteins 0.000 description 2
• 102000016202 Proteolipids Human genes 0.000 description 2
• 230000018199 S phase Effects 0.000 description 2
• 108050000761 Serpin Proteins 0.000 description 2
• 102000008847 Serpin Human genes 0.000 description 2
• 241000710960 Sindbis virus Species 0.000 description 2
• 108700005078 Synthetic Genes Proteins 0.000 description 2
• 230000006052 T cell proliferation Effects 0.000 description 2
• 102100028644 Tenascin-R Human genes 0.000 description 2
• 102100031372 Thymidine phosphorylase Human genes 0.000 description 2
• 102000004338 Transferrin Human genes 0.000 description 2
• 108090000901 Transferrin Proteins 0.000 description 2
• 102100040115 Tumor necrosis factor receptor superfamily member 10C Human genes 0.000 description 2
• 108091005956 Type II transmembrane proteins Proteins 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 241000711975 Vesicular stomatitis virus Species 0.000 description 2
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000006786 activation induced cell death Effects 0.000 description 2
• WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
• 210000002159 anterior chamber Anatomy 0.000 description 2
• YCSBALJAGZKWFF-UHFFFAOYSA-N anthracen-2-amine Chemical compound C1=CC=CC2=CC3=CC(N)=CC=C3C=C21 YCSBALJAGZKWFF-UHFFFAOYSA-N 0.000 description 2
• 239000003242 anti bacterial agent Substances 0.000 description 2
• 230000002424 anti-apoptotic effect Effects 0.000 description 2
• 230000001640 apoptogenic effect Effects 0.000 description 2
• YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
• 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 230000000740 bleeding effect Effects 0.000 description 2
• 210000004204 blood vessel Anatomy 0.000 description 2
• 108010006025 bovine growth hormone Proteins 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• WOCXQMCIOTUMJV-UHFFFAOYSA-N cb1954 Chemical compound C1=C([N+]([O-])=O)C(C(=O)N)=CC(N2CC2)=C1[N+]([O-])=O WOCXQMCIOTUMJV-UHFFFAOYSA-N 0.000 description 2
• 230000030833 cell death Effects 0.000 description 2
• 238000002512 chemotherapy Methods 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 238000004132 cross linking Methods 0.000 description 2
• 229960004397 cyclophosphamide Drugs 0.000 description 2
• 230000001461 cytolytic effect Effects 0.000 description 2
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
• 230000001086 cytosolic effect Effects 0.000 description 2
• 230000034994 death Effects 0.000 description 2
• 230000003210 demyelinating effect Effects 0.000 description 2
• 230000000368 destabilizing effect Effects 0.000 description 2
• ZWAOHEXOSAUJHY-ZIYNGMLESA-N doxifluridine Chemical compound O[C@@H]1[C@H](O)[C@@H](C)O[C@H]1N1C(=O)NC(=O)C(F)=C1 ZWAOHEXOSAUJHY-ZIYNGMLESA-N 0.000 description 2
• 230000008030 elimination Effects 0.000 description 2
• 238000003379 elimination reaction Methods 0.000 description 2
• 201000002491 encephalomyelitis Diseases 0.000 description 2
• 230000002327 eosinophilic effect Effects 0.000 description 2
• 210000003743 erythrocyte Anatomy 0.000 description 2
• 210000003013 erythroid precursor cell Anatomy 0.000 description 2
• 210000002950 fibroblast Anatomy 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 229930182830 galactose Natural products 0.000 description 2
• 108091006104 gene-regulatory proteins Proteins 0.000 description 2
• 230000012010 growth Effects 0.000 description 2
• 230000006801 homologous recombination Effects 0.000 description 2
• 238000002744 homologous recombination Methods 0.000 description 2
• 229920001519 homopolymer Polymers 0.000 description 2
• 230000002209 hydrophobic effect Effects 0.000 description 2
• 229960001101 ifosfamide Drugs 0.000 description 2
• HOMGKSMUEGBAAB-UHFFFAOYSA-N ifosfamide Chemical compound ClCCNP1(=O)OCCCN1CCCl HOMGKSMUEGBAAB-UHFFFAOYSA-N 0.000 description 2
• 230000008076 immune mechanism Effects 0.000 description 2
• 230000008105 immune reaction Effects 0.000 description 2
• 239000002955 immunomodulating agent Substances 0.000 description 2
• 230000001506 immunosuppresive effect Effects 0.000 description 2
• 230000001771 impaired effect Effects 0.000 description 2
• 230000000415 inactivating effect Effects 0.000 description 2
• 238000011534 incubation Methods 0.000 description 2
• 239000000411 inducer Substances 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 206010022000 influenza Diseases 0.000 description 2
• 239000003999 initiator Substances 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 239000008101 lactose Substances 0.000 description 2
• 210000002429 large intestine Anatomy 0.000 description 2
• 230000021633 leukocyte mediated immunity Effects 0.000 description 2
• 210000005229 liver cell Anatomy 0.000 description 2
• 239000002609 medium Substances 0.000 description 2
• 210000003593 megakaryocyte Anatomy 0.000 description 2
• 239000002207 metabolite Substances 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 210000000663 muscle cell Anatomy 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 230000036473 myasthenia Effects 0.000 description 2
• 230000006654 negative regulation of apoptotic process Effects 0.000 description 2
• 230000003076 paracrine Effects 0.000 description 2
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 2
• 230000002085 persistent effect Effects 0.000 description 2
• 210000004180 plasmocyte Anatomy 0.000 description 2
• 101150050662 plcB gene Proteins 0.000 description 2
• 210000001778 pluripotent stem cell Anatomy 0.000 description 2
• 229920000656 polylysine Polymers 0.000 description 2
• 239000013641 positive control Substances 0.000 description 2
• 230000001124 posttranscriptional effect Effects 0.000 description 2
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
• 238000012545 processing Methods 0.000 description 2
• 229940048914 protamine Drugs 0.000 description 2
• 230000002285 radioactive effect Effects 0.000 description 2
• 230000006798 recombination Effects 0.000 description 2
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
• 230000000284 resting effect Effects 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000004062 sedimentation Methods 0.000 description 2
• 239000003001 serine protease inhibitor Substances 0.000 description 2
• 210000000130 stem cell Anatomy 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 206010043207 temporal arteritis Diseases 0.000 description 2
• 229940104230 thymidine Drugs 0.000 description 2
• 229960003087 tioguanine Drugs 0.000 description 2
• 230000000451 tissue damage Effects 0.000 description 2
• 231100000827 tissue damage Toxicity 0.000 description 2
• 230000003614 tolerogenic effect Effects 0.000 description 2
• 230000005030 transcription termination Effects 0.000 description 2
• 239000012581 transferrin Substances 0.000 description 2
• 230000014621 translational initiation Effects 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• 230000009385 viral infection Effects 0.000 description 2
• 239000000277 virosome Substances 0.000 description 2
• QVWYCTGTGHDWFQ-AWEZNQCLSA-N (2s)-2-[[4-[2-chloroethyl(2-methylsulfonyloxyethyl)amino]benzoyl]amino]pentanedioic acid Chemical compound CS(=O)(=O)OCCN(CCCl)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QVWYCTGTGHDWFQ-AWEZNQCLSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• STXXGSWOWSSPRV-UHFFFAOYSA-N 2-[(2-amino-6-oxo-3h-purin-9-yl)methoxy]ethyl phosphono hydrogen phosphate Chemical compound N1C(N)=NC(=O)C2=C1N(COCCOP(O)(=O)OP(O)(O)=O)C=N2 STXXGSWOWSSPRV-UHFFFAOYSA-N 0.000 description 1
• OQPDPIPLWCUACY-UHFFFAOYSA-N 2-aminoethylthiourea;hydrobromide Chemical compound [Br-].NCC[NH+]=C(N)S OQPDPIPLWCUACY-UHFFFAOYSA-N 0.000 description 1
• 108020005345 3' Untranslated Regions Proteins 0.000 description 1
• OSJPPGNTCRNQQC-UWTATZPHSA-N 3-phospho-D-glyceric acid Chemical compound OC(=O)[C@H](O)COP(O)(O)=O OSJPPGNTCRNQQC-UWTATZPHSA-N 0.000 description 1
• OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
• WOVKYSAHUYNSMH-RRKCRQDMSA-N 5-bromodeoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-RRKCRQDMSA-N 0.000 description 1
• GOILPRCCOREWQE-UHFFFAOYSA-N 6-methoxy-7h-purine Chemical compound COC1=NC=NC2=C1NC=N2 GOILPRCCOREWQE-UHFFFAOYSA-N 0.000 description 1
• STQGQHZAVUOBTE-UHFFFAOYSA-N 7-Cyan-hept-2t-en-4,6-diinsaeure Natural products C1=2C(O)=C3C(=O)C=4C(OC)=CC=CC=4C(=O)C3=C(O)C=2CC(O)(C(C)=O)CC1OC1CC(N)C(O)C(C)O1 STQGQHZAVUOBTE-UHFFFAOYSA-N 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 208000002267 Anti-neutrophil cytoplasmic antibody-associated vasculitis Diseases 0.000 description 1
• 102000010565 Apoptosis Regulatory Proteins Human genes 0.000 description 1
• 108010063104 Apoptosis Regulatory Proteins Proteins 0.000 description 1
• 241001167018 Aroa Species 0.000 description 1
• 241001203868 Autographa californica Species 0.000 description 1
• 208000023345 Autoimmune Diseases of the Nervous System Diseases 0.000 description 1
• 208000032116 Autoimmune Experimental Encephalomyelitis Diseases 0.000 description 1
• 108091008875 B cell receptors Proteins 0.000 description 1
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 1
• 101150039990 B13R gene Proteins 0.000 description 1
• WOVKYSAHUYNSMH-UHFFFAOYSA-N BROMODEOXYURIDINE Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C(Br)=C1 WOVKYSAHUYNSMH-UHFFFAOYSA-N 0.000 description 1
• 108010077805 Bacterial Proteins Proteins 0.000 description 1
• 108700032588 Baculovirus p35 Proteins 0.000 description 1
• 102000051485 Bcl-2 family Human genes 0.000 description 1
• 108700038897 Bcl-2 family Proteins 0.000 description 1
• 241000255789 Bombyx mori Species 0.000 description 1
• 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 description 1
• 241000701066 Bovine gammaherpesvirus 4 Species 0.000 description 1
• 241000714266 Bovine leukemia virus Species 0.000 description 1
• 241000701822 Bovine papillomavirus Species 0.000 description 1
• 101000741929 Caenorhabditis elegans Serine/threonine-protein phosphatase 2A catalytic subunit Proteins 0.000 description 1
• 101100408682 Caenorhabditis elegans pmt-2 gene Proteins 0.000 description 1
• 101100367084 Caenorhabditis elegans such-1 gene Proteins 0.000 description 1
• 241000178270 Canarypox virus Species 0.000 description 1
• 102100035904 Caspase-1 Human genes 0.000 description 1
• 108090000426 Caspase-1 Proteins 0.000 description 1
• 206010057248 Cell death Diseases 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 108020004635 Complementary DNA Proteins 0.000 description 1
• 241000711573 Coronaviridae Species 0.000 description 1
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
• 229930105110 Cyclosporin A Natural products 0.000 description 1
• 108010036949 Cyclosporine Proteins 0.000 description 1
• 241001634817 Cydia Species 0.000 description 1
• 102000005927 Cysteine Proteases Human genes 0.000 description 1
• 108010005843 Cysteine Proteases Proteins 0.000 description 1
• 230000005778 DNA damage Effects 0.000 description 1
• 231100000277 DNA damage Toxicity 0.000 description 1
• 108010049207 Death Domain Receptors Proteins 0.000 description 1
• 102000009058 Death Domain Receptors Human genes 0.000 description 1
• 208000016192 Demyelinating disease Diseases 0.000 description 1
• 206010012305 Demyelination Diseases 0.000 description 1
• 201000004624 Dermatitis Diseases 0.000 description 1
• 241000723672 Dianthovirus Species 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
• 102000007989 Effector Caspases Human genes 0.000 description 1
• 108010089510 Effector Caspases Proteins 0.000 description 1
• 101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 description 1
• 108010042407 Endonucleases Proteins 0.000 description 1
• 102000004533 Endonucleases Human genes 0.000 description 1
• 108700041152 Endoplasmic Reticulum Chaperone BiP Proteins 0.000 description 1
• 102100021451 Endoplasmic reticulum chaperone BiP Human genes 0.000 description 1
• 108010069621 Epstein-Barr virus EBV-associated membrane antigen Proteins 0.000 description 1
• 241000701959 Escherichia virus Lambda Species 0.000 description 1
• 241000702191 Escherichia virus P1 Species 0.000 description 1
• 108010077716 Fas-Associated Death Domain Protein Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
• 208000000666 Fowlpox Diseases 0.000 description 1
• 241000700662 Fowlpox virus Species 0.000 description 1
• 241000287828 Gallus gallus Species 0.000 description 1
• 208000018522 Gastrointestinal disease Diseases 0.000 description 1
• 241000713813 Gibbon ape leukemia virus Species 0.000 description 1
• 102000008214 Glutamate decarboxylase Human genes 0.000 description 1
• 108091022930 Glutamate decarboxylase Proteins 0.000 description 1
• 102000001398 Granzyme Human genes 0.000 description 1
• 108060005986 Granzyme Proteins 0.000 description 1
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
• 102000006354 HLA-DR Antigens Human genes 0.000 description 1
• 108010058597 HLA-DR Antigens Proteins 0.000 description 1
• 102100021410 Heat shock 70 kDa protein 14 Human genes 0.000 description 1
• 108010004889 Heat-Shock Proteins Proteins 0.000 description 1
• 102000002812 Heat-Shock Proteins Human genes 0.000 description 1
• 241000711549 Hepacivirus C Species 0.000 description 1
• 208000009889 Herpes Simplex Diseases 0.000 description 1
• 241000238631 Hexapoda Species 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
• 101000914211 Homo sapiens CASP8 and FADD-like apoptosis regulator Proteins 0.000 description 1
• 101000856199 Homo sapiens Chymotrypsin-like protease CTRL-1 Proteins 0.000 description 1
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
• 101001041756 Homo sapiens Heat shock 70 kDa protein 14 Proteins 0.000 description 1
• 101001056180 Homo sapiens Induced myeloid leukemia cell differentiation protein Mcl-1 Proteins 0.000 description 1
• 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 description 1
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 1
• 101100100117 Homo sapiens TNFRSF10B gene Proteins 0.000 description 1
• 101000651211 Homo sapiens Transcription factor PU.1 Proteins 0.000 description 1
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 1
• 101000807008 Homo sapiens Uracil phosphoribosyltransferase homolog Proteins 0.000 description 1
• 108010000521 Human Growth Hormone Proteins 0.000 description 1
• 102000002265 Human Growth Hormone Human genes 0.000 description 1
• 239000000854 Human Growth Hormone Substances 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 102000026633 IL6 Human genes 0.000 description 1
• 108700005091 Immunoglobulin Genes Proteins 0.000 description 1
• 102000016844 Immunoglobulin-like domains Human genes 0.000 description 1
• 108050006430 Immunoglobulin-like domains Proteins 0.000 description 1
• 102100026539 Induced myeloid leukemia cell differentiation protein Mcl-1 Human genes 0.000 description 1
• 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 1
• 102000001483 Initiator Caspases Human genes 0.000 description 1
• 108010054031 Initiator Caspases Proteins 0.000 description 1
• 102100034343 Integrase Human genes 0.000 description 1
• 102000002227 Interferon Type I Human genes 0.000 description 1
• 108010014726 Interferon Type I Proteins 0.000 description 1
• 102000008070 Interferon-gamma Human genes 0.000 description 1
• 108010074328 Interferon-gamma Proteins 0.000 description 1
• 108090000177 Interleukin-11 Proteins 0.000 description 1
• 102000003815 Interleukin-11 Human genes 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 102000000704 Interleukin-7 Human genes 0.000 description 1
• 108090001007 Interleukin-8 Proteins 0.000 description 1
• 102000004890 Interleukin-8 Human genes 0.000 description 1
• 241000713321 Intracisternal A-particles Species 0.000 description 1
• 102100027670 Islet amyloid polypeptide Human genes 0.000 description 1
• 206010023203 Joint destruction Diseases 0.000 description 1
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
• 241001484259 Lacuna Species 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 206010067125 Liver injury Diseases 0.000 description 1
• 241000709757 Luteovirus Species 0.000 description 1
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 1
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 1
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
• 241000700560 Molluscum contagiosum virus Species 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 208000010428 Muscle Weakness Diseases 0.000 description 1
• 241000700562 Myxoma virus Species 0.000 description 1
• 229930193140 Neomycin Natural products 0.000 description 1
• 241000772415 Neovison vison Species 0.000 description 1
• 208000012902 Nervous system disease Diseases 0.000 description 1
• 208000009869 Neu-Laxova syndrome Diseases 0.000 description 1
• 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 description 1
• 102000005348 Neuraminidase Human genes 0.000 description 1
• 108010006232 Neuraminidase Proteins 0.000 description 1
• 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
• 101710163270 Nuclease Proteins 0.000 description 1
• 108010027206 Nucleopolyhedrovirus inhibitor of apoptosis Proteins 0.000 description 1
• 108700020796 Oncogene Proteins 0.000 description 1
• 102000043276 Oncogene Human genes 0.000 description 1
• 241000052303 Orgyia pseudotsugata multiple nucleopolyhedrovirus Species 0.000 description 1
• 240000007019 Oxalis corniculata Species 0.000 description 1
• 208000031481 Pathologic Constriction Diseases 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 1
• 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
• 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
• 102100026918 Phospholipase A2 Human genes 0.000 description 1
• 108010058864 Phospholipases A2 Proteins 0.000 description 1
• 108091000080 Phosphotransferase Proteins 0.000 description 1
• 108010033737 Pokeweed Mitogens Proteins 0.000 description 1
• 241001505332 Polyomavirus sp. Species 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 108010029485 Protein Isoforms Proteins 0.000 description 1
• 102000001708 Protein Isoforms Human genes 0.000 description 1
• 102000001253 Protein Kinase Human genes 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 101710150344 Protein Rev Proteins 0.000 description 1
• 101710149951 Protein Tat Proteins 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
• 206010037742 Rabies Diseases 0.000 description 1
• 101000836070 Rattus norvegicus Serine protease inhibitor A3L Proteins 0.000 description 1
• 101150071286 SPI-2 gene Proteins 0.000 description 1
• 241000710961 Semliki Forest virus Species 0.000 description 1
• 101710142113 Serine protease inhibitor A3K Proteins 0.000 description 1
• 101710181917 Serine proteinase inhibitor 1 Proteins 0.000 description 1
• 101710181913 Serine proteinase inhibitor 2 Proteins 0.000 description 1
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
• 241000714229 Simian retrovirus 1 Species 0.000 description 1
• 241000713675 Spumavirus Species 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 1
• 241000143014 T7virus Species 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 241000710914 Totivirus Species 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102100027654 Transcription factor PU.1 Human genes 0.000 description 1
• 101710097160 Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 1
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 1
• 108090000848 Ubiquitin Proteins 0.000 description 1
• 102000044159 Ubiquitin Human genes 0.000 description 1
• 102100037717 Uracil phosphoribosyltransferase homolog Human genes 0.000 description 1
• 108700005077 Viral Genes Proteins 0.000 description 1
• 101710146079 Xanthine-guanine phosphoribosyltransferase Proteins 0.000 description 1
• 230000001270 agonistic effect Effects 0.000 description 1
• 230000000961 alloantigen Effects 0.000 description 1
• 102000013640 alpha-Crystallin B Chain Human genes 0.000 description 1
• 108010051585 alpha-Crystallin B Chain Proteins 0.000 description 1
• 229960000723 ampicillin Drugs 0.000 description 1
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
• 206010002022 amyloidosis Diseases 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 208000007502 anemia Diseases 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 239000002215 arabinonucleoside Substances 0.000 description 1
• 229940114079 arachidonic acid Drugs 0.000 description 1
• 235000021342 arachidonic acid Nutrition 0.000 description 1
• 101150037081 aroA gene Proteins 0.000 description 1
• 108010084541 asialoorosomucoid Proteins 0.000 description 1
• 229940009098 aspartate Drugs 0.000 description 1
• 210000001130 astrocyte Anatomy 0.000 description 1
• 244000309743 astrovirus Species 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 208000035362 autoimmune disorder of the nervous system Diseases 0.000 description 1
• 230000000468 autoproteolytic effect Effects 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 210000003651 basophil Anatomy 0.000 description 1
• XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
• 230000003851 biochemical process Effects 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 239000012620 biological material Substances 0.000 description 1
• 230000007321 biological mechanism Effects 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000001772 blood platelet Anatomy 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 229950004398 broxuridine Drugs 0.000 description 1
• AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
• 230000003197 catalytic effect Effects 0.000 description 1
• 230000020411 cell activation Effects 0.000 description 1
• 238000004113 cell culture Methods 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000032823 cell division Effects 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 230000007248 cellular mechanism Effects 0.000 description 1
• 230000036755 cellular response Effects 0.000 description 1
• 238000005119 centrifugation Methods 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 235000013330 chicken meat Nutrition 0.000 description 1
• 210000001612 chondrocyte Anatomy 0.000 description 1
• 229960004407 chorionic gonadotrophin Drugs 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 229960001265 ciclosporin Drugs 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 239000013599 cloning vector Substances 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 239000008119 colloidal silica Substances 0.000 description 1
• 230000000536 complexating effect Effects 0.000 description 1
• 210000002808 connective tissue Anatomy 0.000 description 1
• 238000011109 contamination Methods 0.000 description 1
• 230000001276 controlling effect Effects 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 229930182912 cyclosporin Natural products 0.000 description 1
• 235000018417 cysteine Nutrition 0.000 description 1
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
• 231100000263 cytotoxicity test Toxicity 0.000 description 1
• SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
• SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
• 229960000975 daunorubicin Drugs 0.000 description 1
• STQGQHZAVUOBTE-VGBVRHCVSA-N daunorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
• 238000000354 decomposition reaction Methods 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000006735 deficit Effects 0.000 description 1
• 238000000432 density-gradient centrifugation Methods 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000000779 depleting effect Effects 0.000 description 1
• 229960004679 doxorubicin Drugs 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 230000012202 endocytosis Effects 0.000 description 1
• 210000001163 endosome Anatomy 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 101150030339 env gene Proteins 0.000 description 1
• YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
• 210000003979 eosinophil Anatomy 0.000 description 1
• 230000001747 exhibiting effect Effects 0.000 description 1
• 210000003499 exocrine gland Anatomy 0.000 description 1
• 208000012997 experimental autoimmune encephalomyelitis Diseases 0.000 description 1
• 238000000684 flow cytometry Methods 0.000 description 1
• 239000012530 fluid Substances 0.000 description 1
• 229960002949 fluorouracil Drugs 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 229960002963 ganciclovir Drugs 0.000 description 1
• IRSCQMHQWWYFCW-UHFFFAOYSA-N ganciclovir Chemical compound O=C1NC(N)=NC2=C1N=CN2COC(CO)CO IRSCQMHQWWYFCW-UHFFFAOYSA-N 0.000 description 1
• 210000001035 gastrointestinal tract Anatomy 0.000 description 1
• 102000034356 gene-regulatory proteins Human genes 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 102000054766 genetic haplotypes Human genes 0.000 description 1
• 229960002989 glutamic acid Drugs 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 208000024963 hair loss Diseases 0.000 description 1
• 230000003676 hair loss Effects 0.000 description 1
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 1
• 231100000234 hepatic damage Toxicity 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 230000028996 humoral immune response Effects 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• 230000001969 hypertrophic effect Effects 0.000 description 1
• 230000007124 immune defense Effects 0.000 description 1
• 230000001900 immune effect Effects 0.000 description 1
• 230000036737 immune function Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000002434 immunopotentiative effect Effects 0.000 description 1
• 230000003308 immunostimulating effect Effects 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 230000008595 infiltration Effects 0.000 description 1
• 238000001764 infiltration Methods 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 230000005865 ionizing radiation Effects 0.000 description 1
• PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
• PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
• 150000002500 ions Chemical class 0.000 description 1
• UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 1
• 229960004768 irinotecan Drugs 0.000 description 1
• 210000004153 islets of langerhan Anatomy 0.000 description 1
• 210000003292 kidney cell Anatomy 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 230000008818 liver damage Effects 0.000 description 1
• 230000006674 lysosomal degradation Effects 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 210000003071 memory t lymphocyte Anatomy 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• QVDXUKJJGUSGLS-LURJTMIESA-N methyl L-leucinate Chemical compound COC(=O)[C@@H](N)CC(C)C QVDXUKJJGUSGLS-LURJTMIESA-N 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• 230000007193 modulation by symbiont of host erythrocyte aggregation Effects 0.000 description 1
• 210000003643 myeloid progenitor cell Anatomy 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000012177 negative regulation of immune response Effects 0.000 description 1
• 229960004927 neomycin Drugs 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 210000000440 neutrophil Anatomy 0.000 description 1
• 230000005937 nuclear translocation Effects 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 230000030648 nucleus localization Effects 0.000 description 1
• 235000015097 nutrients Nutrition 0.000 description 1
• 238000004091 panning Methods 0.000 description 1
• 210000004738 parenchymal cell Anatomy 0.000 description 1
• 230000000149 penetrating effect Effects 0.000 description 1
• 229930192851 perforin Natural products 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 210000003024 peritoneal macrophage Anatomy 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 102000020233 phosphotransferase Human genes 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 230000004260 plant-type cell wall biogenesis Effects 0.000 description 1
• 230000008092 positive effect Effects 0.000 description 1
• 230000035935 pregnancy Effects 0.000 description 1
• 210000001948 pro-b lymphocyte Anatomy 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• 230000000770 proinflammatory effect Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 229950008679 protamine sulfate Drugs 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 108060006633 protein kinase Proteins 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 150000003212 purines Chemical group 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000002829 reductive effect Effects 0.000 description 1
• 230000025915 regulation of apoptotic process Effects 0.000 description 1
• 108091008146 restriction endonucleases Proteins 0.000 description 1
• 230000003307 reticuloendothelial effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 230000001359 rheumatologic effect Effects 0.000 description 1
• 210000003079 salivary gland Anatomy 0.000 description 1
• 210000004739 secretory vesicle Anatomy 0.000 description 1
• 210000002966 serum Anatomy 0.000 description 1
• 239000013605 shuttle vector Substances 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 208000017520 skin disease Diseases 0.000 description 1
• 210000000813 small intestine Anatomy 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 230000002269 spontaneous effect Effects 0.000 description 1
• 238000010186 staining Methods 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 231100000617 superantigen Toxicity 0.000 description 1
• 239000006228 supernatant Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 210000001258 synovial membrane Anatomy 0.000 description 1
• 210000005222 synovial tissue Anatomy 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 210000001550 testis Anatomy 0.000 description 1
• 229960000814 tetanus toxoid Drugs 0.000 description 1
• 230000008719 thickening Effects 0.000 description 1
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
• 230000024664 tolerance induction Effects 0.000 description 1
• 231100000167 toxic agent Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000002103 transcriptional effect Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 102000035160 transmembrane proteins Human genes 0.000 description 1
• 108091005703 transmembrane proteins Proteins 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 241000701447 unidentified baculovirus Species 0.000 description 1
• 241000701451 unidentified granulovirus Species 0.000 description 1
• 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 230000008299 viral mechanism Effects 0.000 description 1
• 230000006490 viral transcription Effects 0.000 description 1
• 208000012498 virus associated tumor Diseases 0.000 description 1
• 230000004580 weight loss Effects 0.000 description 1